Cargando…

H(1)-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects – A Retrospective Survey Study

BACKGROUND: The guidelines recommend that first line treatment of chronic spontaneous urticaria should be second generation non-sedating H(1)-antihistamines with a positive recommendation against the use of old sedating first generation antihistamines. If standard dosing is not effective, increasing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weller, Karsten, Ziege, Claudia, Staubach, Petra, Brockow, Knut, Siebenhaar, Frank, Krause, Karoline, Altrichter, Sabine, Church, Martin K., Maurer, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164658/ https://www.ncbi.nlm.nih.gov/pubmed/21909407 http://dx.doi.org/10.1371/journal.pone.0023931

Ejemplares similares

Lower IgA Levels in Chronic Spontaneous Urticaria Are Associated With Lower IgE Levels and Autoimmunity
por: Sauer, Merle, et al.
Publicado: (2021)

Inhibition of interleukin‐1 with rilonacept is not effective in cold urticaria—Results of a randomized, placebo‐controlled study
por: Bonnekoh, Hanna, et al.
Publicado: (2023)

Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
por: Durda, J., et al.
Publicado: (2017)

Total IgE as a Marker for Chronic Spontaneous Urticaria
por: Altrichter, Sabine, et al.
Publicado: (2021)

Pathobiology of Second-Generation Antihistamines Related to Sleep in Urticaria Patients
por: Mann, Caroline, et al.
Publicado: (2022)

Fenebrutinib in H(1) antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial
por: Metz, Martin, et al.
Publicado: (2021)

Disease Impact, Diagnostic Delay, and Unmet Medical Needs of Patients With Cholinergic Urticaria in German-Speaking Countries
por: Altrichter, Sabine, et al.
Publicado: (2022)

Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria
por: van den Elzen, Mignon T., et al.
Publicado: (2017)

Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria
por: Kolkhir, Pavel, et al.
Publicado: (2021)

Cryoglobulins, Cryofibrinogens, and Cold Agglutinins in Cold Urticaria: Literature Review, Retrospective Patient Analysis, and Observational Study in 49 Patients
por: Ginter, Katharina, et al.
Publicado: (2021)

Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects
por: Shamizadeh, Soja, et al.
Publicado: (2014)

IgE Mediated Autoallergy against Thyroid Peroxidase – A Novel Pathomechanism of Chronic Spontaneous Urticaria?
por: Altrichter, Sabine, et al.
Publicado: (2011)

Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey
por: Krause, Karoline, et al.
Publicado: (2023)

In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria
por: Moñino‐Romero, Sherezade, et al.
Publicado: (2023)

A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria
por: Puhl, Viktoria, et al.
Publicado: (2021)

Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria – Results from the validation of the Polish Urticaria Control Test()
por: Brzoza, Zenon, et al.
Publicado: (2022)

Autologous Whole Blood Injection for the Treatment of Antihistamine-Resistant Chronic Spontaneous Urticaria
por: You, Hyang-Suk, et al.
Publicado: (2015)

Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know
por: Terhorst-Molawi, Dorothea, et al.
Publicado: (2023)

Case report: Severe chronic spontaneous urticaria successfully treated with omalizumab and dupilumab
por: Puxkandl, Viktoria, et al.
Publicado: (2023)

Features of Antihistamine-Resistant Chronic Urticaria and Chronic Urticaria During Exacerbation
por: Huilan, Zhu, et al.
Publicado: (2015)

Why a Complete Response Is the Treatment Aim in Chronic Spontaneous Urticaria
por: Bernstein, Jonathan A., et al.
Publicado: (2023)

On the Lipophilic Nature of Autoreactive IgE in Chronic Spontaneous Urticaria
por: Lakin, Elisa, et al.
Publicado: (2019)

Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria
por: Giménez‐Arnau, Ana, et al.
Publicado: (2022)

Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria
por: Kocatürk, Emek, et al.
Publicado: (2019)

Bepotastine-induced urticaria, cross-reactive with other antihistamines
por: Kang, Ju Wan, et al.
Publicado: (2016)

Omalizumab rapidly improves angioedema‐related quality of life in adult patients with chronic spontaneous urticaria: X‐ACT study data
por: Staubach, P., et al.
Publicado: (2017)

Pharmacology of Antihistamines
por: Church, Martin K, et al.
Publicado: (2013)

Pharmacology of Antihistamines
por: Church, Diana S, et al.
Publicado: (2011)

Night-time sedating H(1)-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial
por: Staevska, M, et al.
Publicado: (2014)

Management of chronic spontaneous urticaria: a worldwide perspective
por: Kolkhir, Pavel, et al.
Publicado: (2018)

Sensitization against skin resident fungi is associated with atopy in cholinergic urticaria patients
por: Altrichter, Sabine, et al.
Publicado: (2020)

Altered Gut Microbiota in H1-Antihistamine-Resistant Chronic Spontaneous Urticaria Associates With Systemic Inflammation
por: Song, Yao, et al.
Publicado: (2022)

Chronic recurrent wheals – If not chronic spontaneous urticaria, what else?
por: Bonnekoh, Hanna, et al.
Publicado: (2023)

Drug eruption by antihistamine mistaken for chronic urticaria in a child
por: Lee, Gun Moo, et al.
Publicado: (2019)

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H(1) Antihistamines: A Randomized, Placebo-Controlled Study
por: Saini, Sarbjit S, et al.
Publicado: (2015)

Up-dosing with bilastine results in improved effectiveness in cold contact urticaria
por: Krause, K, et al.
Publicado: (2013)

Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study
por: Ulambayar, Bastsetseg, et al.
Publicado: (2019)

Variations of Thiol–Disulfide Homeostasis Parameters after Treatment with H1-Antihistamines in Patients with Chronic Spontaneous Urticaria
por: Matei, Clara, et al.
Publicado: (2021)

STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
por: Sauer, Merle, et al.
Publicado: (2022)

Editorial: The complexity of urticaria
por: Makris, Michael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6a434et71fa18o8edim6vbem4q